Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

RAET1E inhibits KLRK1. 3 / 3

| 3

➶

reach

"RAET1E2, a soluble isoform of the UL16 binding protein RAET1E produced by tumor cells, inhibits NKG2D mediated NK cytotoxicity."

17470428

➶

reach

"In other words, RAET1E might impair NKG2D mediated NK cell cytotoxicity to tumors [XREF_BIBR]."

| PMC

➶

reach

"We previously reported that RAET1E2, a soluble isoform of the RAET1E (ULBP4), inhibits NKG2D mediated NK cytotoxicity."

19436053

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

RAET1E inhibits KLRK1. 3 / 3

Our Sources:

Databases

Reading